store at low temperature
store at -20°C
Emicizumab(ACE 910) is a humanized monoclonal antibody that bridges activated factor IX and activated factor X to mimic the function of activated factor VIII. Emicizumab is used for the prevention and treatment of hemophilia A. It has been shown to be effective in the treatment of hemophilia A. It has been shown to be effective in the prevention and treatment of hemophilia A.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 1,980.00 | |
5 mg | In stock | $ 4,160.00 | |
10 mg | In stock | $ 5,620.00 | |
25 mg | In stock | $ 8,360.00 | |
50 mg | In stock | $ 11,200.00 | |
100 mg | In stock | $ 15,200.00 |
Description | Emicizumab(ACE 910) is a humanized monoclonal antibody that bridges activated factor IX and activated factor X to mimic the function of activated factor VIII. Emicizumab is used for the prevention and treatment of hemophilia A. It has been shown to be effective in the treatment of hemophilia A. It has been shown to be effective in the prevention and treatment of hemophilia A. |
In vivo |
Emicizumab (1.5-10 mg/kg; i.v.; 24 hours before tail-clip bleeding) partially corrects blood loss in a hemophilia type A bleeding model with an FVIII equivalent of 9 U/dL.[1] Emicizumab (3 mg/kg; intravenously) provides additional hemostatic activity when combined with low-dose FVIII (10 U/dL).[1] |
Synonyms | ACE 910, RO 5534262 |
Molecular Weight | N/A |
CAS No. | 1610943-06-0 |
store at low temperature
store at -20°C
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Emicizumab 1610943-06-0 Others ACE 910 ACE-910 RO-5534262 ACE910 RO 5534262 RO5534262 inhibitor inhibit